reported that colorectal cancer patients with high-expression of AQP9 exhibited better survival rate compared with the low-expression counterpart, suggesting that AQP9 could be used as an independent predictor of adjuvant chemotherapy for colorectal cancer. The gene discussed is AQP9; the disease is colorectal cancer.